Literature DB >> 8888377

Pharmacokinetics and pharmacodynamics of methylphenidate enantiomers in rats.

T Aoyama1, H Kotaki, Y Sawada, T Iga.   

Abstract

We investigated the relationships between methylphenidate (MPD) enantiomers and endogenous dopamine (DA) levels in striatal extracellular fluid, and that between DA level and locomotor activity, after intravenous administration of racemic MPD (2, 5 or 10 mg/kg dose) or the individual enantiomers (2.5 mg/kg dose) to rats. MPD and DA levels in the extracellular fluid were measured by in vivo brain microdialysis. The maximum levels of MPD enantiomers in the striatal extracellular fluid were obtained within 15 min after administration. On the other hand, the mean maximum DA levels after administration of 2-10 mg/kg dose of racemic MPD were obtained within 10 min with values in the range of 3.0- to 8.6-fold higher than the basal DA level. The maximum DA level (4.2-fold of the basal level) after administration of (+/-)-MPD was greater than that (2.2-fold) of the same dose of (-)-MPD. A clockwise hysteresis was observed between MPD concentration and DA level in the extracellular fluid after MPD administration. Locomotor activity after administration of (+)-MPD was also greater than (-)-MPD. From these results, it was shown that the locomotor activity induced by MPD may be related to the increase of DA level in the extracellular fluid, and the degree of increase of the DA level by (+)-MPD was greater than that of the (-)-isomer.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8888377     DOI: 10.1007/bf02805984

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  18 in total

1.  Characterisation of methylphenidate and nomifensine induced dopamine release in rat striatum using in vivo brain microdialysis.

Authors:  S P Butcher; J Liptrot; G W Aburthnott
Journal:  Neurosci Lett       Date:  1991-01-28       Impact factor: 3.046

2.  Gas chromatographic-mass spectrometric analysis of threo-methylphenidate enantiomers in plasma.

Authors:  T Aoyama; H Kotaki; Y Saitoh
Journal:  J Chromatogr       Date:  1989-09-29

3.  Evidence for dopamine receptor stimulation by apomorphine.

Authors:  N E Andén; A Rubenson; K Fuxe; T Hökfelt
Journal:  J Pharm Pharmacol       Date:  1967-09       Impact factor: 3.765

4.  Observations on effects of a central stimulant drug (methylphenidate) in children with hyperactive behavior.

Authors:  R J Schain; C L Reynard
Journal:  Pediatrics       Date:  1975-05       Impact factor: 7.124

5.  Autoradiographic localization of [3H]methylphenidate binding sites in rat brain.

Authors:  A S Unis; T M Dawson; D R Gehlert; J K Wamsley
Journal:  Eur J Pharmacol       Date:  1985-07-11       Impact factor: 4.432

6.  In vivo neurochemical profile of dopamine uptake inhibitors and releasers in rat caudate-putamen.

Authors:  Y L Hurd; U Ungerstedt
Journal:  Eur J Pharmacol       Date:  1989-07-18       Impact factor: 4.432

7.  Development of enantioselective gas chromatographic quantitation assay for dl-threo-methylphenidate in biological fluids.

Authors:  H K Lim; J W Hubbard; K K Midha
Journal:  J Chromatogr       Date:  1986-05-28

8.  Enhancing effect of methamphetamine on ambulatory activity produced by repeated administration in mice.

Authors:  M Hirabayashi; M R Alam
Journal:  Pharmacol Biochem Behav       Date:  1981-12       Impact factor: 3.533

9.  The effects of anesthetics on the concentrations of cholecystokinin octapeptide sulfate-like immunoreactivity in rat brain regions.

Authors:  Y Kushima; K Takeda; Y Oh-Hashi; T Nakagawa; T Kato
Journal:  Neuropeptides       Date:  1989 Nov-Dec       Impact factor: 3.286

10.  Stereospecific distribution of methylphenidate enantiomers in rat brain: specific binding to dopamine reuptake sites.

Authors:  T Aoyama; H Kotaki; Y Sawada; T Iga
Journal:  Pharm Res       Date:  1994-03       Impact factor: 4.200

View more
  7 in total

Review 1.  Pharmacokinetics and clinical effectiveness of methylphenidate.

Authors:  H C Kimko; J T Cross; D R Abernethy
Journal:  Clin Pharmacokinet       Date:  1999-12       Impact factor: 6.447

Review 2.  A review of psychostimulant-induced neuroadaptation in developing animals.

Authors:  Normand Carrey; Michael Wilkinson
Journal:  Neurosci Bull       Date:  2011-06       Impact factor: 5.203

Review 3.  Methylphenidate and its isomers: their role in the treatment of attention-deficit hyperactivity disorder using a transdermal delivery system.

Authors:  David J Heal; David M Pierce
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749

4.  Pharmacodynamic modeling for change of locomotor activity by methylphenidate in rats.

Authors:  T Aoyama; K Yamamoto; H Kotaki; Y Sawada; T Iga
Journal:  Pharm Res       Date:  1997-11       Impact factor: 4.200

5.  Plasma and brain concentrations of oral therapeutic doses of methylphenidate and their impact on brain monoamine content in mice.

Authors:  Aygul Balcioglu; Jia-Qian Ren; Deirdre McCarthy; Thomas J Spencer; Joseph Biederman; Pradeep G Bhide
Journal:  Neuropharmacology       Date:  2009-07-22       Impact factor: 5.250

6.  Juvenile methylphenidate exposure and factors that influence incentive processing.

Authors:  Heather C Brenhouse; Lee Napierata; Lucinda Kussmaul; Melanie Leussis; Susan L Andersen
Journal:  Dev Neurosci       Date:  2009-04-17       Impact factor: 2.984

7.  Semi-Automated Biomarker Discovery from Pharmacodynamic Effects on EEG in ADHD Rodent Models.

Authors:  Tatsuya Yokota; Zbigniew R Struzik; Peter Jurica; Masahito Horiuchi; Shuichi Hiroyama; Junhua Li; Yuji Takahara; Koichi Ogawa; Kohei Nishitomi; Minoru Hasegawa; Andrzej Cichocki
Journal:  Sci Rep       Date:  2018-03-26       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.